Organism: Homo sapiens
Gene: 38921_at
Selected probe(set): 206444_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38921_at (206444_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-1.7732172
Number of Samples:5 / 7

Experimental	HIV-associated neurocognitive disorder study 9 (HIVE)
	Postmortem cerebral white matter tissue from HIV-1-infected patients with substantial HIV-associated neurocognitive impairment (HAND). Patients had no encephalitis (HIVE) or other neuropathological defect.
Control	HIV-associated dementia study 1
	Postmortem basal ganglia tissue from HIV-1-infected patients with substantial HIV-associated neurocognitive impairment (HAND). Patients had no encephalitis (HIVE) or other neuropathological defect.

Relative Expression (log2-ratio):1.4985809
Number of Samples:2 / 3

Experimental	expO stomach cancer study 1 (gastrointestinal stromal tumor; primary)
	Primary tumor tissue samples obtained from the stomach of patients with gastrointestinal stromal tumor.
Control	expO stomach cancer study 1 (adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the stomach of patients with adenocarcinoma (NOS).

Relative Expression (log2-ratio):1.2613344
Number of Samples:2 / 2

Experimental	cadmium study 1 (brief)
	After 72h of starvation, NPrEC cells were briefly exposed to 2.5 uM CdCl2. ATC code:---
Control	untreated NPrEC cell sample
	After 72h of starvation, NPrEC cells were briefly exposed to complete medium without CdCl2.

Relative Expression (log2-ratio):1.2485237
Number of Samples:4 / 2

Experimental	oxyphilic adenoma study 1
	Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma).
Control	normal kidney tissue (fetal)
	Normal fetal kidney tissue samples.

Relative Expression (log2-ratio):1.1857061
Number of Samples:3 / 2

Experimental	PMA study 2 (shRNA contr.)
	MONO-MAC-6 (MM6) cells were transduced with a control shRNA and then treated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA). ATC code:---
Control	mock treated / transduced MONO-MAC-6 cell sample
	MONO-MAC-6 (MM6) cells were transduced with a control shRNA and then mock treated.

Relative Expression (log2-ratio):-1.1834564
Number of Samples:3 / 3

Experimental	influenza virus study 11 (A/H5N3)
	Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F119/3/1997(H5N3). Samples were taken 10 hours post-infection.
Control	influenza virus study 4 (A/H1N1)
	Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection.

Relative Expression (log2-ratio):1.1632862
Number of Samples:3 / 2

Experimental	PMA study 2
	MONO-MAC-6 (MM6) cells were treated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA). ATC code:---
Control	mock treated MONO-MAC-6 cell sample
	MONO-MAC-6 (MM6) cells mock treated.

Relative Expression (log2-ratio):1.0854349
Number of Samples:2 / 2

Experimental	conditioned medium study 1 (HS5)
	CD14+ monocytes treated with HS5 conditioned medium (CM) for 48h.
Control	untreated monocyte (CD14+) sample
	Untreated CD14+ monocytes from two different donors.

Relative Expression (log2-ratio):-1.05233
Number of Samples:5 / 7

Experimental	HIV-associated neurocognitive disorder study 10 (HIVE)
	Postmortem frontal cortex tissue from HIV-1-infected patients with substantial HIV-associated neurocognitive impairment (HAND). Patients had no encephalitis (HIVE) or other neuropathological defect.
Control	HIV-associated dementia study 1
	Postmortem basal ganglia tissue from HIV-1-infected patients with substantial HIV-associated neurocognitive impairment (HAND). Patients had no encephalitis (HIVE) or other neuropathological defect.

Relative Expression (log2-ratio):1.0469561
Number of Samples:2 / 2

Experimental	conditioned medium study 1 (HS27a)
	CD14+ monocytes treated with HS27a conditioned medium (CM) for 48h.
Control	untreated monocyte (CD14+) sample
	Untreated CD14+ monocytes from two different donors.